What is the clinical evidence from this study?

Study design: Review. Population: Patients presenting with acute chest pain undergoing HEART score risk stratification. Intervention: HEART score risk stratification vs. Not applicable (mathematical modeling and re-analysis of published data). Primary outcome: 30-day major adverse cardiac event (MACE) rate (Exponential model MACE (%) = 0.79 × e^(0.44×HEART) (R²≈0.99), 95% CI HEART 0: 0.0-0.3%; HEART 1: 0.0-1.8%; HEART 2: 0.0-3.5%; HEART 3: 0.4-4.8%; HEART 4: 1.8-7.2%; HEART 5: 4.0-12.0%; HEART 6: 7.0-18.0%; HEART 7: 12.0-23.0%).

What question did this study set out to answer?

This report aims to evaluate the precision of the HEART score in predicting major adverse cardiac events.

March 4, 2026Open Access

Exponential Modeling and Confidence Interval Analysis Reveal Limited Precision of History, Electrocardiogram, Age, Risk Factors, and Troponin (HEART) Score Risk Stratification

Key Result

HEART score 0-1 combined with non-ischemic ECG and serial negative hs-troponins reliably predicts <1% 30-day MACE risk, while HEART scores 1-3 show substantial risk overlap and limited statistical separability.

Key Points

This report aims to evaluate the precision of the HEART score in predicting major adverse cardiac events.
Utilized exponential modeling to assess risk behavior of HEART score
Conducted confidence interval analysis for MACE prediction
Compared various HEART score strata and ECG results
The model showed substantial overlap in confidence intervals across HEART score levels 1-3
Only HEART scores 0-1 with specific ECG and troponin results met the <1% MACE guideline
Findings refine the interpretation of intermediate HEART strata

Structured PICO

Population

Patients presenting with acute chest pain from foundational HEART score derivation and validation cohorts (per-stratum sample sizes ranging from approximately the low hundreds to low thousands).

Intervention

HEART score risk stratification evaluated via exponential modeling and confidence interval analysis

Outcome

30-day major adverse cardiac event (MACE) ratescomposite

Exponential modeling reveals that HEART scores 1-3 have overlapping confidence intervals and are statistically indistinguishable, suggesting only HEART scores 0-1 reliably identify patients with <1% 30-day MACE risk for early discharge.

Main Result

Effect estimate: Exponential model MACE (%) = 0.79 × e^(0.44×HEART) (R²≈0.99) (95% CI HEART 0: 0.0-0.3%; HEART 1: 0.0-1.8%; HEART 2: 0.0-3.5%; HEART 3: 0.4-4.8%; HEART 4: 1.8-7.2%; HEART 5: 4.0-12.0%; HEART 6: 7.0-18.0%; HEART 7: 12.0-23.0%)

Limitations

Study is a secondary mathematical re-analysis using published summary-level data, not prospective patient-level risk prediction.
Original HEART score derivation cohorts predated widespread use of high-sensitivity troponin assays limiting direct applicability.
No new validation or clinical trial was performed, results depend on reanalysis and modeling of existing data.
Revascularization included in MACE composite may exaggerate differences between score strata.

Abstract

Using exponential modeling and confidence interval (CI) analysis, this report evaluates the internal risk behavior of the history, electrocardiogram, age, risk factors, and troponin (HEART) score. The exponential model major adverse cardiac event (MACE %) = 0.79 × e(0.44·HEART) (R²≈0.99) demonstrates substantial CI overlap across HEART 1-3. Only HEART 0-1, combined with non-ischemic ECG and serial negative high-sensitivity troponins, reliably satisfies the American College of Cardiology/American Heart Association (ACC/AHA) <1% 30-day MACE definition. These findings refine the interpretation of intermediate HEART strata and clarify guideline-aligned use.

Bookmark

View Full Paper

Bookmark

View Full Paper

Cite This Study

David Dobies (Sun,) conducted a review in Patients presenting with acute chest pain undergoing HEART score risk stratification. HEART score risk stratification vs. Not applicable (mathematical modeling and re-analysis of published data) was evaluated on 30-day major adverse cardiac event (MACE) rate (Exponential model MACE (%) = 0.79 × e^(0.44×HEART) (R²≈0.99), 95% CI HEART 0: 0.0-0.3%; HEART 1: 0.0-1.8%; HEART 2: 0.0-3.5%; HEART 3: 0.4-4.8%; HEART 4: 1.8-7.2%; HEART 5: 4.0-12.0%; HEART 6: 7.0-18.0%; HEART 7: 12.0-23.0%). HEART score 0-1 combined with non-ischemic ECG and serial negative hs-troponins reliably predicts <1% 30-day MACE risk, while HEART scores 1-3 show substantial risk overlap and limited statistical separability.

synapsesocial.com/papers/69a7cc4cd48f933b5eed7fa0 https://doi.org/https://doi.org/10.7759/cureus.104506